Revenue | ₹1.46Cr |
Net Profits | ₹1.07Cr |
Net Profit Margins | 73.29% |
Welcure Drugs & Pharmaceuticals Ltd’s revenue jumped 65.91% since last year same period to ₹1.46Cr in the Q3 2025-2026. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated -97.78% fall in its revenue since last 3-months.
Welcure Drugs & Pharmaceuticals Ltd’s net profit jumped 2575% since last year same period to ₹1.07Cr in the Q3 2025-2026. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated -87.41% fall in its net profits since last 3-months.
Welcure Drugs & Pharmaceuticals Ltd’s net profit margin jumped 1512.33% since last year same period to 73.29% in the Q3 2025-2026. On a quarterly growth basis, Welcure Drugs & Pharmaceuticals Ltd has generated 465.78% jumped in its net profit margins since last 3-months.
The revenue for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was ₹1.46Cr.
The net profit for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was ₹1.07Cr.
The net profit margin for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was 73.29%.
The revenue for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.88Cr.
The net profit for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.04Cr.
The net profit margin for Welcure Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was 4.55%.